TENX

Tenax Therapeutics Inc
2.15
0.07 (3.37%)
Company Name Stock Ticker Symbol Market Type
Tenax Therapeutics Inc TENX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.07 3.37% 2.15 19:24:55
Open Price Low Price High Price Close Price Prev Close
2.07 2.055 2.25 2.24 2.08
more quote information »

Recent News

Date Time Source Heading
1/23/202316:50EDGARSecurities Registration Statement (s-1)
1/06/202316:32EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
1/06/202316:31EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
11/14/202206:35TRMNTenax Therapeutics (TENX) Receives a Buy from H.C...
11/10/202216:34EDGARQuarterly Report (10-q)
10/11/202208:31EDGARCurrent Report Filing (8-k)
9/23/202216:48EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
9/23/202216:35EDGARStatement of Changes in Beneficial Ownership (4)
9/20/202216:31EDGARCurrent Report Filing (8-k)
9/15/202209:01EDGARCurrent Report Filing (8-k)
8/18/202216:31EDGARCurrent Report Filing (8-k)
8/17/202206:25TRMNH.C. Wainwright Sticks to Their Buy Rating for Tenax..
8/12/202216:40EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
8/12/202216:24EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202217:17EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
6/16/202216:36EDGARCurrent Report Filing (8-k)
6/10/202216:32EDGARCurrent Report Filing (8-k)
6/06/202206:03EDGARNotice of Effectiveness (effect)
6/03/202216:13EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
5/25/202216:35EDGARSecurities Registration Statement (simplified Form) (s-3)
5/20/202216:53EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
5/20/202216:32EDGARCurrent Report Filing (8-k)
5/16/202217:52EDGARQuarterly Report (10-q)
4/13/202216:31EDGARProxy Statement - Notice of Shareholders Meeting..
3/31/202209:26SEEKTenax Therapeutics GAAP EPS of -$1.58 misses by $1.51
3/29/202216:42EDGARAnnual Report (10-k)
3/24/202208:16EDGARCurrent Report Filing (8-k)
2/18/202216:35EDGARCurrent Report Filing (8-k)
1/31/202216:30EDGARCurrent Report Filing (8-k)